Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005646
Abstract: Background Corticosteroids are the mainstay of treatment for immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI), but the optimal duration of therapy has not been established. Prolonged use of corticosteroids can cause numerous adverse effects and… read more here.
Keywords: longer duration; shorter duration; icpi aki; duration ... See more keywords